Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYour GP can prescribe Wegovy in the UK, but whether they will depends on strict NHS criteria, local funding decisions, and whether your practice has opted into the new prescribing arrangements — which is far from guaranteed. Wegovy (semaglutide 2.4mg injection) is a prescription-only medicine that requires clinical assessment before any prescription is issued. Here is what the NHS route realistically looks like, and where the gaps tend to fall.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A lot of people assume that if they ask their GP and tick the right boxes, a Wegovy prescription follows. That is not how the NHS pathway works. NICE's appraisal of semaglutide (TA875) specifies that it should be used within a specialist weight management service (think tier 3 or 4 multidisciplinary teams) for a maximum of two years, and only for adults with a BMI of 35 or above (or 30–34.9 if specialist-referral criteria are met). Standard GP practices sit outside that framework. So even a sympathetic GP who recognises you'd benefit from treatment may simply not have the commissioning structure around them to write that prescription on the NHS.
Waiting lists for specialist weight management services are long in most parts of England. Some areas have waiting times measured in years rather than months, and availability differs considerably between ICBs. Scotland, Wales and Northern Ireland operate under different criteria again. Your GP can refer you, but they cannot fast-track you to the front of a queue that does not move quickly.
The one thing GPs can do is make sure you are properly assessed and referred to the right service when you meet criteria. That is valuable, and worth asking for. It is just not the same as a same-week prescription.
Even if your GP cannot prescribe Wegovy directly on the NHS today, the appointment has real practical value. They can check whether your weight-related conditions (high blood pressure, type 2 diabetes, dyslipidaemia, obstructive sleep apnoea) are documented in your records. That documentation matters both for NHS referrals and for any private clinical assessment you pursue. A GP can also flag contraindications: a personal or family history of medullary thyroid carcinoma, pancreatitis, or conditions affecting the gut that would make semaglutide unsuitable regardless of route.
If you are considering a private prescription, a conversation with your GP first is sensible, and our guide to seeing a GP about Wegovy explains what to expect from that appointment and how to get the most from it. They can tell you what is already in your Summary Care Record and whether anything there would affect a prescriber's decision. The NHS patient information on semaglutide is also a solid starting point for understanding what you'd be taking and what to expect.
One thing our prescribers hear regularly: patients who assumed their GP would know about the private route and were surprised to find they did not. Private prescribing of licensed medicines is legal and regulated, but it sits outside the NHS, so GPs are not always across the detail of how it works. That is worth knowing before you go in.
Private prescribing of Wegovy follows the same licence conditions as the NHS, the medicine, the eligibility criteria, and the clinical standards are identical. What changes is who carries out the assessment and whether a specialist waiting list is involved. A GPhC-registered Independent Prescriber at a regulated online pharmacy reviews your consultation, your ID, and your current weight before any prescription is issued. There is no referral required. There is no waiting list.
If you want to understand how the results compare between semaglutide and the other licensed option, the evidence on weight loss from Wegovy is worth reading before your consultation. And if cost is part of your thinking, the Wegovy cost page sets out what a legitimate private prescription realistically includes (the prescription itself, clinical assessment, and delivery) so you can compare fairly.
The key safeguard, whether NHS or private, is clinical review before every prescription. A prescriber who skips that step is not following the rules. Any seller offering semaglutide without a proper assessment is operating outside the law, and the MHRA has warned explicitly about counterfeit weight-loss pens being sold online. If you are unsure about the origins of the medication itself, our page on where Wegovy is manufactured and sourced from covers what you need to know. Verify any pharmacy on the GPhC register before you share health information or payment details.
The licensed eligibility for Wegovy is broader than what NHS commissioning currently covers. The medicine is licensed for adults with a BMI of 30 or above, or 27 and above with at least one weight-related condition, conditions such as prediabetes, hypertension, high cholesterol, or obstructive sleep apnoea all count. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. That is the clinical licence. The NHS, following NICE TA875, funds it within a narrower band and only in specialist services.
Private prescribers work to the licensed criteria, not the NHS commissioning criteria. That means if you have a BMI of 30 with well-documented hypertension and your GP has been unable to refer you because local waiting lists are full, you may well meet the criteria for a private prescription assessment. A prescriber still makes that call individually, there is no guarantee of approval, and BMI alone is never the whole picture.
You can read more about how to access Wegovy without a GP referral or explore the full range of weight loss treatments available through a regulated private service. If you'd like to see who reviews consultations at nume, our clinical team page sets that out plainly.
A private consultation is the place to start if you want a same-day answer on whether you're eligible. Check your eligibility with our prescribers at no cost, with no obligation to proceed.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.